Document is current
Any future updates will be listed below
-
Authors
Braun, Molly R.
Nguyen, Lam-Quynh
Flitter, Becca A.
Bennett, Nicholas J.
Hailey, Darreann Carmela M.
Lester, Colin A.
Neuhaus, Elena D.
Marx, Kirsten
D’Amato, Nick P.
Tam, Kayan
Pasetti, Marcela F.
Tucker, Sean N.
Cummings, James F.
-
Funding
Funding for this research was provided by:
The Bill and Melinda Gates Foundation (INV-051351)
The Bill and Melinda Gates Foundation (INV-051351)
The Bill and Melinda Gates Foundation (INV-051351)
The Bill and Melinda Gates Foundation (INV-051351)
The Bill and Melinda Gates Foundation (INV-051351)
The Bill and Melinda Gates Foundation (INV-051351)
The Bill and Melinda Gates Foundation (INV-051351)
The Bill and Melinda Gates Foundation (INV-051351)
The Bill and Melinda Gates Foundation (INV-051351)
The Bill and Melinda Gates Foundation (INV-051351)
The Bill and Melinda Gates Foundation (INV-051351)
Vaxart, Inc
- License Information
-
More Information
Article History
Received: 26 July 2025
Accepted: 17 December 2025
First Online: 14 January 2026
Competing interests
: M.B., N.B., B.F., D.H., E.N., N.D., S.T., and J.C. are employees and shareholders of Vaxart, Inc. who funded this study. L.N., C.L., and K.T. were employees of Vaxart, Inc. and still holds shares in Vaxart stock. S.T. is listed on a patent application involving VXA-G1.1-NN and VXA-G2.4-NS. All other authors declare no competing interests.
